7 Life science trends

Rapid advances in precision medicine will fundamentally change healthcare. Digitalisation and AI, together with new advanced therapies and materials, create completely new values for both companies and healthcare providers – and not least for people who can become healthier and live longer. Read about seven trends that are shaping the life science sector right now.  

Strong life science trends that can improve people's lives

One of Sweden's fastest growing sectors is life science, which contributes more export income than traditionally strong industries such as passenger cars, iron and steel, and paper products.  

In simple terms, life science is about improving people's health – for example, through the development of pharmaceuticals and medical devices, research and education on health, and through new, growing innovation companies. A strong life science sector is a prerequisite for a functioning future healthcare system.

Gothenburg has long had a strong position in this fast-growing sector. And the position is getting stronger as entire industries now converge. This requires open innovation processes, fruitful encounters that lead to cross-fertilisation, which is natural to everyday business life in Gothenburg, and part of the city's DNA.

Fantastic development projects are underway here. This is demanding new knowledge, skills and partnerships. Together with the life science cluster in the region, Business Region Göteborg has developed this trend report – the updated 2025 version.

What’s particularly hot right now? In which areas do we see the advances that have the potential to fundamentally change healthcare? 

Here's our roundup:

1. First-class environments realize great ideas
2. Increasingly important to control wounds and infections
3. Incurable diseases soon to be curable with advanced therapies
4. More efficient healthcare and better decisions with digitalisation and AI
5. Better care and quality of life with self-monitoring and medical IoT
6. Huge opportunities with medical imaging and simulation
7. Advanced implants and 3D printed tissues

Throughout, it is about integrating and taking advantage of advanced technology – together with the people concerned – to create a more efficient and personalised healthcare system.

1. First-class environments realize great ideas

Often, new ideas are born in the unexpected encounter. Properly cared for, these ideas can lead to innovations of great importance for care and quality of life. The challenge in life science lies in creating these fruitful encounters.

To realise the values that digitalisation and rapid technological development enable, specialists need to be able to meet other types of specialists. Disciplines need to cross-fertilise, even from different industrial sectors. That is precisely why so much energy is being spent right now – all over the world – on creating top environments for open innovation, where fruitful encounters can take place. Between different kinds of cutting-edge expertise.

In the Gothenburg area, this takes place in and around both AstraZeneca's research and development facility and Sahlgrenska University Hospital, for example – two key players in European life science.

Pharmaceutical company AstraZeneca has 3,000 employees at its global R&D centre in Gothenburg, which is one of the group's total of six. Inside the facility you find the AstraZeneca BioVentureHub, where small private and academic teams work, participating in open innovation. They benefit from all the resources of the big company, without being controlled by AstraZeneca.

Adjacent to the R&D site AstraZeneca’s partner Steptura has created GoCo Health Innovation City – an entire district in Mölndal filled with innovative players, which is developing quickly and successfully.

Small development companies that outgrow the BioVentureHub tend to stay in the GoCo area to continue to benefit from the quality of this GoCo environment. The concept is proven to work. GoCo attracts international companies, investments and cutting-edge expertise.

American medical technology giant Thermo Fisher Scientific is now opening a bioanalytical laboratory at GoCo and initiating a close collaboration with AstraZeneca. Thermo Fisher's investments in Gothenburg will benefit scientific co-creation on a whole new level, throughout Europe.

Sahlgrenska Life is a development of the environments in and around Sahlgrenska University Hospital for roughly the same reasons. The interaction between research, healthcare, society and the business community will increase. Right now, a completely new emergency department is being built as a first step. Both the hospital and the University of Gothenburg are intensifying their collaboration with AstraZeneca in several different ways, creating a bridge between Medicinarberget and GoCo in Gothenburg.
 

2. Increasingly important to control wounds and infections

Bacteria that are resistant to penicillin and other antibiotics are a growing problem, currently estimated to cost the lives of 79,000 people every year in OECD countries. The last resort drugs are less effective on difficult-to-treat infections such as pneumonia and infected blood.  

Concern about new viruses is also growing. If things go badly, society can be completely dependent on the ability to manage and control infections. This became painfully clear during the coronavirus pandemic.  

Preventing infections is also extremely important in the care of patients with severe wounds or weakened immune systems. Add to that the constant threat of infections that occur while receiving health care and it's easy to see why infection control is an increasingly prioritized area. Good control means that hospital stays can be shortened, illnesses avoided, and costs saved. 

In the Gothenburg region, there are over 60 companies that together cover the entire field of infection control, including major global players. There is prominent research in both academia and industry, for example on graphene as a bactericidal material. 

There are many collaborations in areas such as wound care and antibiotic resistance. The development companies Inicure and 1928 Diagnostics focus on the antibiotic resistance problem.

Sahlgrenska University Hospital has a specialist group that works with healthcare-associated infections, for example in children who have undergone heart surgery, and was also the first to discover a drug for tuberculosis and thromboses. The world's first effective drinkable cholera vaccine, Dukoral, was developed at the University of Gothenburg. A Nordic master's programme in infection control is offered here. The large company Getinge has many complete solutions for sterilization, in many cases world-leading.

Some of the most exciting advances are taking place in the intersection of infection control and materials science. The startup company Amferia has developed an antimicrobial hydrogel that binds and kills antibiotic-resistant bacteria. 

3. Incurable diseases soon to be curable with advanced therapies

Imagine a future where it is possible to cure Parkinson's disease, diabetes, cancer, or blindness. Imagine if organs, tissues, and functions that are completely or partially impossible to repair today can suddenly be recreated. The idea is mind-blowing, but with regenerative medicine and Advanced Therapy Medicinal Products (ATMPs), we may be facing a paradigm shift in healthcare with completely new opportunities and methods to treat almost all types of diseases.

Regenerative medicine is concerned with repairing defective genes, replacing or recreating human cells, tissues or organs. ATMPs are drugs based on genes, cells and tissues. These new biologics have the potential to revolutionize healthcare with personalized treatments for diseases such as cancer, diabetes, and cardiovascular diseases – and even rare genetic diseases that have not previously been curable, or even treatable. This is a very promising area of precision medicine, tailored to each individual.

The Gothenburg region has many strengths in advanced therapies, not least through actors at BioVentureHub, the collaboration that takes place there and within CCRM Nordic. In terms of business, there is great potential in manufacturing and scale-up of these methods, but there is a need for business models that allow the cost of these expensive treatments to be managed.

Advanced therapies for several types of diseases are already being carried out at Sahlgrenska University Hospital, both with approved drugs and in clinical trials. The hospital is the only hospital in the Nordic region to have a special centre for ATMP in the treatment of children, including cancer. The Sahlgrenska ATMP Centre brings together the clinical research that is ongoing in advanced therapies.

Several niche startups across the spectrum of opportunities make the development even more exciting, including Cellink, Fluicell and Elicera therapeutics. The University of Gothenburg's holding company GU Ventures invests in a wide range of drug development companies, together with other investors.  

Gothenburg has the potential to make a big impression internationally. Advanced therapies for several types of diseases are already being used at Sahlgrenska University Hospital, both with approved drugs and in clinical trials. The hospital is the only hospital in the Nordic region to use ATMPs in the treatment of children, including cancer. Ribocure is a clinical-stage biotechnology company developing cutting-edge RNA therapies. 

4. More efficient healthcare and better decisions with digitalisation and AI

A lot has happened since the early days of medicine, but much of today's healthcare is still based on human assumptions and judgments. It often gets it right, but not always. As long as human error is involved, there is a risk that patients will be misdiagnosed, mistreated or treated too late.

This is where digitalisation and AI can be of great benefit. Digitalisation in healthcare has been going on for a long time, but the potential is far from fully exploited when it comes to, for example, the management of patient data. Efficient digital systems make it easier to use, update and share patient information between different healthcare providers, reducing the risk of mistakes and improving treatment outcomes in cases such as cancer or stroke. This is something that the EU is trying to facilitate by pointing out a stable direction in terms of ethics around health data and AI. 

With AI as the brain of decision support systems, doctors and other healthcare professionals will have completely new opportunities to make informed decisions. AI algorithms can be used, among other things, to predict risks by seeing patterns in the patient's medical record. At Sahlgrenska, for example, they try to predict risks for patients with heart failure and have also succeeded in reducing the number of fall injuries in healthcare, with the help of AI.

The best results are achieved if you set up the systems and care based on the patients (see the next trend). That is why Sahlgrenska University Hospital and Region Västra Götaland are investing heavily in patient centred healthcare. The University of Gothenburg also hosts Sweden's Centre for Person-Centred Care. Publicly driven collaborations such as the Innovation Platform and Gothia Forum work in parallel to facilitate testing and validation of innovations in healthcare. This also benefits more mature companies that are often responsible for innovation in e-health.

Many private healthcare providers in Gothenburg, such as Capio and Carlanderska, have successfully driven their digitalisation. In elderly care, Norlandia is an innovative and leading player, with operations at GoCo.

Perhaps the most exciting AI-supported development in the region is taking place in drug development, imaging technology and patient data. Here, life science companies benefit from progress in other strong industries, and national cross-fertilisation through, for example, AI Sweden, Chalmers' AI initiative Chair and advances in quantum computing. 

5. Better care and quality of life with self-monitoring and medical IoT

Not having to be hospitalized, or not having to visit a health center or hospital for ongoing check-ups has many advantages. The patient's quality of life improves, the risk of infections is reduced, time and resources are saved in healthcare. With the development of medical IoT – the Internet of medical things, or telemedicine – this is about to become a reality.

Through Sahlgrenska hemma, the hospital has taken an important step into people's everyday life. The potential is great and the opportunities are many: 

• Fewer hospital visits for patients with chronic diseases.
• Patient data that is collected on an ongoing basis provides a better basis for medical decisions.
• Better access to care, especially in remote areas.
• Possibility of early detection of health problems, and fine-tuned treatment.
• More efficient use of healthcare resources and greater opportunities to offer individualised care.

In medical IoT and AI, there are several interesting growth companies in Gothenburg, which have sprung from the region's cutting-edge ecosystem in life science.  They offer products that users and patients can benefit greatly from.

• Sleep Cycle is a fast-growing company that offers an app that monitors the sleep of millions of users in 150 countries daily. The app helps users understand their sleep habits and improve their sleep, and can wake the user up in the right sleep phase. The company's statistics contribute to research and reporting on sleep worldwide.
• Evinova has a system for self-monitoring patients, participating in clinical trials
• Cuviva offers a digital platform for the care of people with multiple chronic illnesses and the frail elderly. The patient receives an easy-to-use piece of hardware at home that a nurse can install and explain. With the solution in place, healthcare professionals and families can communicate, and get joint control of sampling, monitoring and health planning. In Mölndal, for example, patients measure their own blood sugar, blood pressure, pulse and weight and have continuous contact with health care digitally.
• By briefly filming a person's eye, the company Sightic Analytics can detect if a person is using drugs, alcohol or medications that impair cognitive ability. Sightic's software can be used in the driver's environment or other contexts where traditional drug tests – saliva, urine, and blood samples – cannot be used.
• Detectivio has developed technology to scan a face from one metre away and thereby perceive vital signs of value for emergency departments, telemedicine and home care. Can also be useful in vehicles, in offices or at events.
• Albus Health monitors breathing, coughing, and other markers during the night in people participating in clinical trials.

6. Huge opportunities with medical imaging and simulation

Recent major advances in medical imaging technology provide entirely new benefits and opportunities for both patients and healthcare providers. With AI and machine learning, researchers and doctors can help interpret medical images, and can more easily detect details and abnormalities that are difficult for the human eye to see. Increased resolution and detail constantly make diagnoses more precise.

For a few years now, Sahlgrenska University Hospital in Gothenburg has been equipped with a state-of-the-art Imaging and intervention centre (image below), where the latest imaging technology is used for both diagnosis and intervention. Many new areas of application are being explored.  

Here, advanced procedures are carried out with the help of keyhole surgery, small tools and robots on, for example, tumours in the brain, monitored by advanced magnetic resonance imaging. These can stop acute bleeding, fix broken backs, replace heart valves, remove clots from the brain, dilate calcified vessels and much more. Usually through minimally invasive procedures through small portals in the skin. 

Cardiologists, oncologists, surgeons and other specialists are also trained in new technologically advanced methods, both live, via screen and in a fully simulated environment. 

• The Gothenburg-based company Mentice has over 100 employees and supplies such simulation equipment for the training of heart surgeons, both software and hardware, to ten countries.
• Surgical Science is an even larger company that specializes in training resident physicians in a simulated environment before embarking on live operations. Software from both companies is embedded by other global medtech companies in their products.
• Ortoma is a third company that supports orthopaedic surgery with the help of an online platform.

Advanced imaging technology can also be of great benefit in clinical trials. Antaros Medical uses it to study the biology of diseases and how drugs interact with the body, as early decision-making data in the development of different types of drugs.

The medical technology company Profundus is developing a camera and software system that can read the retina in the eye and hopefully contribute to making early diagnoses of eye diseases.

Gothenburg-based Mentice has over 100 employees and delivers such simulation equipment for the training of heart surgeons, both software and hardware, to ten countries. Surgical Science is an even larger company that specializes in training resident physicians in a simulated environment before embarking on live operations. Software from both companies is embedded by other global medtech companies in their products. Ortoma is a third company that uses a platform based on AI to support orthopaedic surgery. 

7. Advanced implants and 3D printed tissues

Shortage of human organs is a major global problem. Gothenburg contributes in many ways to increasing the availability of human organs and tissues. For example, the high-tech company Xvivo Perfusion keeps donated vital organs such as lungs, hearts, and livers alive until transplantation, and is a world leader in recovering lungs through warm perfusion.  

But imagine not having to wait for a suitable organ to be available for donation. Imagine if it was possible to create an artificial liver, or maybe even a heart, that is a copy of the original organ, and that fits the body perfectly. That would be an incredible win for patients who need organs. More lives could be saved, and there would be fewer complications.

Verigraft develops regenerative medicine products based on recycled blood vessels, and other donated human tissue. A clinical study now under way is testing how patients with chronic vein disease react when they have had the biotech company's personalized blood vessels implanted.

It sounds like science fiction, but the fact is that even 3D-printed organs could become a reality in the foreseeable future. Research and development are ongoing all over the world, not least in Gothenburg, where Bico-owned Cellink has received international attention for its development of bioprinters and bioinks for the world's research environments.  

3D technology may also play an important role in implants and prostheses that can replace worn-out or destroyed parts of the body. Plastic surgeons at Sahlgrenska University have begun trials to insert the first 3D-printed implants on humans – initially in the subcutaneous fat of the upper arm, as a first step.

Another area is pharmaceutical production, where 3D technology can be used to produce medicines with personalized dosages or unique combinations of active substances.

Gothenburg has a long and strong tradition in implants, ever since Per-Ingvar Brånemark discovered in the 1960s that titanium grows together with bone. The phenomenom is called osseointegration, and it gave rise to Nobel Biocare, which has since treated millions of patients around the world.

Today, Dentsply Sirona is a leader in dental implants, but the technology is central to all types of bone-anchored implants. Cochlear is the global leader in implantable hearing solutions. Both companies have development and an important presence in Gothenburg. Cochlear has recently launched Implants that can be upgraded with new software – inside the body. Growth company Promimic develops smart surface treatment for bone anchored implants. 

Another company, Intelligent Implants, develops implants with built-in electronics that stimulate, control and measure bone growth, primarily in the lumbar spine.